Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials Article (Web of Science)

cited authors

  • Carlson, Julie A.; Reddy, Krishna; Gaspar, Laurie E.; Ney, Douglas; Kavanagh, Brian D.; Damek, Denise; Lillehei, Kevin; Chen, Changhu

publication date

  • June 1, 2015

webpage

published in

author keyword

  • Bevacizumab
  • GBM
  • Glioblastoma multiforme
  • Intensity modulated radiation therapy

category

start page

  • 251

end page

  • 257

volume

  • 123

issue

  • 2